©The Author(s) 2015.
World J Gastroenterol. Aug 7, 2015; 21(29): 8888-8893
Published online Aug 7, 2015. doi: 10.3748/wjg.v21.i29.8888
Published online Aug 7, 2015. doi: 10.3748/wjg.v21.i29.8888
Table 1 Patient characteristics (n = 95)
| Variables | Value |
| Sex, male/female | 76/19 |
| Age (yr): median (range) | 68 (37-82) |
| ECOG-PS: 0/1/2 | 62/28/5 |
| Etiology HBV/HCV/Others | 72/12/11 |
| Child-Pugh: A/B/C | 49/42/4 |
| Maximum tumor diameter (mm): median (range) | 30.0 (10.0-160.0) |
| Tumor distribution: unilateral/bilateral | 22/73 |
| Portal vein tumor thrombosis: yes/no | 19/76 |
| AFP (ng/mL), median (range) | 86.0 (1.9-5856.0) |
| DCP (mAU/mL), median (range) | 117 (0-204030) |
| Previous treatment | |
| Surgical resection | 4 |
| PEI | 25 |
| RFA | 8 |
| TACE | 34 |
| None | 24 |
- Citation: Suzuki E, Chiba T, Ooka Y, Ogasawara S, Tawada A, Motoyama T, Kanogawa N, Saito T, Yoshikawa M, Yokosuka O. Transcatheter arterial infusion for advanced hepatocellular carcinoma: Who are candidates? World J Gastroenterol 2015; 21(29): 8888-8893
- URL: https://www.wjgnet.com/1007-9327/full/v21/i29/8888.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i29.8888